Product Information
JORNAY PM 40 MG CAPSULE is a brand product labeled by Ironshore Pharmaceuticals Inc., priced at $15.4139 per EA under NDC 71376020203. Its NADAC has been published 349 times since Oct 23, 2019.
The High Outlier badge above means this manufacturer's average price in the Methylphenidate Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Ironshore Pharmaceuticals Inc.NDC
71376020203
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA209311On Market Since
6/1/2019
Pharmacological Classes
Price Statistics
The NADAC for JORNAY PM 40 MG CAPSULE has been published 349 times since Oct 23, 2019, and over the history we have for it it has risen 30.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.4139 per EA |
|---|---|
| All-time high | $15.4200 (Jun 10, 2026) |
| All-time low | $11.8350 (Oct 23, 2019) |
| 52-week high | $15.4200 |
| 52-week low | $14.9567 |
| Median price | $13.8565 |
| Average price | $13.6316 |
| Largest weekly change | +6.1% (Aug 5, 2020) |
| Weeks tracked | 349 |
| Tracking since | Oct 23, 2019 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of JORNAY PM 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for JORNAY PM 40 MG CAPSULE, manufactured by Ironshore Pharmaceuticals Inc., is $15.4139 per EA (NDC 71376020203), effective Jun 24, 2026.
How has the price of JORNAY PM 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for JORNAY PM 40 MG CAPSULE has risen 30.2%. It has been tracked across 349 weekly CMS publications since Oct 23, 2019.
What are the highest and lowest recorded NADAC prices for JORNAY PM 40 MG CAPSULE?
Since Oct 23, 2019, the NADAC for JORNAY PM 40 MG CAPSULE has ranged from a low of $11.8350 (Oct 23, 2019) to a high of $15.4200 (Jun 10, 2026), with a median of $13.8565 per EA.
Are there cheaper alternatives to JORNAY PM 40 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METHYLPHENIDATE ER(CD) 40 MG CP, is $1.4221 per EA — about 91% below JORNAY PM 40 MG CAPSULE.
Who manufactures JORNAY PM 40 MG CAPSULE?
JORNAY PM 40 MG CAPSULE (NDC 71376020203) is labeled by Ironshore Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification